Fragment-Based Drug Discovery
From Proteopedia
(Difference between revisions)
| Line 15: | Line 15: | ||
Click on each amino acid to view the hydrophobic interactions with the ligand: | Click on each amino acid to view the hydrophobic interactions with the ligand: | ||
| - | •<scene name='Sandbox_reserved_394/Tyrosine_199/3'>Tyr199</scene> | + | {{multiCol}}•<scene name='Sandbox_reserved_394/Tyrosine_199/3'>Tyr199</scene>{{colBreak}} |
| + | •<scene name='Sandbox_reserved_394/Valine_145/1'>Val145</scene>{{endMultiCol}} | ||
| - | •<scene name='Sandbox_reserved_394/ | + | {{multiCol}}•<scene name='Sandbox_reserved_394/Leucine_134/1'>Leu134</scene>{{colBreak}} |
| + | •<scene name='Sandbox_reserved_394/Phe109_and_ala108/1'>Phe109</scene>{{endMultiCol}} | ||
| - | •<scene name='Sandbox_reserved_394/ | + | {{multiCol}}•<scene name='Sandbox_reserved_394/Phe109_and_ala108/1'>Ala108</scene>{{colBreak}} |
| + | •<scene name='Sandbox_reserved_394/Tyrosine_105/1'>Tyr105</scene>{{endMultiCol}} | ||
| - | •<scene name='Sandbox_reserved_394/ | + | {{multiCol}}•<scene name='Sandbox_reserved_394/Phe_101/1'>Phe101</scene>{{colBreak}} |
| - | + | •<scene name='Sandbox_reserved_394/Glycine_142/1'>Gly142</scene>{{endMultiCol}} | |
| - | •<scene name='Sandbox_reserved_394/ | + | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
</StructureSection> | </StructureSection> | ||
Revision as of 23:07, 25 September 2012
Paclitaxel in Apoptosis
| |||||||||||
